We need your support!
The FDA has recently called a hearing to decide the future of access to homeopathic medicine and we need your help to protect our country’s health freedom. The FDA is reevaluating their “regulatory framework” for homoeopathic remedies. Friends and supporters of homeopathy have to act immediately to tell the FDA that they want to maintain their freedom to use homeopathic medicines.
The hearing will be on April 20 and April 21, 2015. You can send materials to the FDA to support access to homeopathic remedies. Materials must be received by the FDA by June 22, 2015. Comment online at Regulations.gov or by mail to Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Be sure to include the docket number “HFA-305” in any correspondence to the FDA. The hearing will be broadcast live at Collaboration.FDA.gov.
The FDA wants to hear from patients and consumers, as well as from health care providers and those selling or manufacturing homeopathic medicines. You can apply to speak in person or listen to the live meeting. You will be able to listen to the live broadcast of the meeting and comment afterwards. The comment period is open until June 22, 2015.
Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, rm. 1061
Rockville, MD 20852
Include docket number HFA-305 in all correspondence.
2260 Pool Road
Grapevine, TX 76051
Dr. Constantine A. Kotsanis MD complements traditional medicine with functional medicine and nutrition to optimize health, wellness, and the anti-aging process.
Dr. Kotsanis specialties include Insulin Potentiation Targeted Low Dose Therapy (IPTLDSM) in the treatment of Cancer, Comprehensive Cancer Care & AfterCare, Autism, Hormone Imbalances, Allergies, Digestive Disorders, Chronic Fatigue and Chronic Disorders.
The Kotsanis Institute is located located in Grapevine, Texas – close to Dallas Fort Worth International Airport (DFW)